Company / Gross Profit
Perspective Therapeutics, Inc. Gross Profit History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
-
FY2022
5-year range
$0 / $3.0M
FY2018-FY2022
Trend
-100.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $2M to $0 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, gross profit decreased 100.0% year-over-year.
- Peak gross profit was recorded in FY2021.
- Lowest gross profit in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0 | -100.0% |
| FY2021 | $3.0M | +65.4% |
| FY2020 | $1.8M | +119.8% |
| FY2019 | $838.0K | +549.6% |
| FY2018 | $129.0K | -22.8% |
| FY2017 | $167.0K | +185.0% |
| FY2016 | -$196.5K | -230.8% |
| FY2015 | $150.2K | +0.0% |
| FY2014 | $150.2K | -78.6% |
| FY2013 | $703.2K | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026